PURPOSE OF REVIEW: This article presents a practical approach to the evaluation of patients with rapidly progressive dementia. RECENT FINDINGS: The approach presented in this article builds upon the standard dementia evaluation, leveraging widely available tests and emergent specific markers of disease to narrow the differential diagnosis and determine the cause(s) of rapid progressive decline. The discovery of treatment-responsive causes of rapidly progressive dementia underscores the need to determine the cause early in the symptomatic course when treatments are most likely to halt or reverse cognitive decline. SUMMARY: A pragmatic and organized approach to patients with rapidly progressive dementia is essential to mitigate diagnostic and therapeutic challenges and optimize patient outcomes.
PURPOSE OF REVIEW: This article presents a practical approach to the evaluation of patients with rapidly progressive dementia. RECENT FINDINGS: The approach presented in this article builds upon the standard dementia evaluation, leveraging widely available tests and emergent specific markers of disease to narrow the differential diagnosis and determine the cause(s) of rapid progressive decline. The discovery of treatment-responsive causes of rapidly progressive dementia underscores the need to determine the cause early in the symptomatic course when treatments are most likely to halt or reverse cognitive decline. SUMMARY: A pragmatic and organized approach to patients with rapidly progressive dementia is essential to mitigate diagnostic and therapeutic challenges and optimize patient outcomes.
Authors: G D Rabinovici; P N Wang; J Levin; L Cook; M Pravdin; J Davis; S J DeArmond; N M Barbaro; J Martindale; B L Miller; M D Geschwind Journal: Neurology Date: 2006-01-24 Impact factor: 9.910
Authors: Natasha Warikoo; Samuel J Brunwasser; Ann Benz; Hong-Jin Shu; Steven M Paul; Michael Lewis; James Doherty; Michael Quirk; Laura Piccio; Charles F Zorumski; Gregory S Day; Steven Mennerick Journal: J Neurosci Date: 2018-02-23 Impact factor: 6.167
Authors: Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka Journal: Neurology Date: 2017-06-07 Impact factor: 9.910
Authors: Amaia Muñoz-Lopetegi; Marienke A A M de Bruijn; Sanae Boukhrissi; Anna E M Bastiaansen; Mariska M P Nagtzaam; Esther S P Hulsenboom; Agnita J W Boon; Rinze F Neuteboom; Juna M de Vries; Peter A E Sillevis Smitt; Marco W J Schreurs; Maarten J Titulaer Journal: Neurol Neuroimmunol Neuroinflamm Date: 2020-03-02
Authors: Peter Maat; Janet W de Beukelaar; Casper Jansen; Maaike Schuur; Cornelia M van Duijn; Marleen H van Coevorden; Esther de Graaff; Maarten Titulaer; Annemieke J Rozemuller; Peter Sillevis Smitt Journal: Neurol Neuroimmunol Neuroinflamm Date: 2015-11-12